439 related articles for article (PubMed ID: 16357103)
1. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor.
Echchgadda I; Song CS; Roy AK; Chatterjee B
Mol Pharmacol; 2004 Mar; 65(3):720-9. PubMed ID: 14978251
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
6. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
8. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
10. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
Peng L; Malloy PJ; Feldman D
Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
[TBL] [Abstract][Full Text] [Related]
11. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
[TBL] [Abstract][Full Text] [Related]
13. Xenobiotic- and vitamin D-responsive induction of the steroid/bile acid-sulfotransferase Sult2A1 in young and old mice: the role of a gene enhancer in the liver chromatin.
Seo YK; Chung YT; Kim S; Echchgadda I; Song CS; Chatterjee B
Gene; 2007 Jan; 386(1-2):218-23. PubMed ID: 17123747
[TBL] [Abstract][Full Text] [Related]
14. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
15. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.
Kim RH; Li JJ; Ogata Y; Yamauchi M; Freedman LP; Sodek J
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):219-26. PubMed ID: 8761475
[TBL] [Abstract][Full Text] [Related]
16. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
Wu Y; Craig TA; Lutz WH; Kumar R
Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
Barletta F; Freedman LP; Christakos S
Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
Chen X; Chen F; Liu S; Glaeser H; Dawson PA; Hofmann AF; Kim RB; Shneider BL; Pang KS
Mol Pharmacol; 2006 Jun; 69(6):1913-23. PubMed ID: 16481392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
